Furthermore, the expression of bFGF and its receptor in lymphoma cells has a prognostic significance: bFGF expression is correlated with worse survival and PFS, and FGFR-1 expression is correlated with decreased rate of achievement of complete remission and in the subgroup with DLBCL with worse survival and PFS. Here, FGFR1 is linked to lymphoma.